Home LiteratureArticle Details
PMID: 18462013 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells.

PLoS medicine ·Vol. 5 ·No. 5 ·2008-05-06 ·Pages e100

Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, Meier A, Brumme CJ, Rosenberg ES, Alter G, Allen TM, Walker BD, Altfeld M

Abstract

Virus-specific CD8(+) T lymphocytes play a key role in the initial reduction of peak viremia during acute viral infections, but display signs of increasing dysfunction and exhaustion under conditions of chronic antigen persistence. It has been suggested that virus-specific CD8(+) T cells with a "polyfunctional" profile, defined by the capacity to secrete multiple cytokines or chemokines, are most competent in controlling viral replication in chronic HIV-1 infection. We used HIV-1 infection as a model of chronic persistent viral infection to investigate the process of exhaustion and dysfunction of virus-specific CD8(+) T cell responses on the single-epitope level over time, starting in primary HIV-1 infection. We longitudinally analyzed the polyfunctional epitope-specific CD8(+) T cell responses of 18 patients during primary HIV-1 infection before and after therapy initiation or sequence variation in the targeted epitope. Epitope-specific CD8(+) T cells responded with multiple effector functions to antigenic stimulation during primary HIV-1 infection, but lost their polyfunctional capacity in response to antigen and up-regulated programmed death 1 (PD-1) expression with persistent viremic infection. This exhausted phenotype significantly decreased upon removal of stimulation by antigen, either in response to antiretroviral therapy or by reduction of epitope-specific antigen load in the presence of ongoing viral replication, as a consequence of in vivo selection of cytotoxic T lymphocyte escape mutations in the respective epitopes. Monofunctionality increased in CD8(+) T cell responses directed against conserved epitopes from 49% (95% confidence interval 27%-72%) to 76% (56%-95%) (standard deviation [SD] of the effect size 0.71), while monofunctionality remained stable or slightly decreased for responses directed against escaped epitopes from 61% (47%-75%) to 56% (42%-70%) (SD of the effect size 0.18) (p < 0.05). These data suggest that persistence of antigen can be the cause, rather than the consequence, of the functional impairment of virus-specific T cell responses observed during chronic HIV-1 infection, and underscore the importance of evaluating autologous viral sequences in studies aimed at investigating the relationship between virus-specific immunity and associated pathogenesis.

MeSH Terms
Anti-Retroviral Agents/pharmacology Antigens, Viral/chemistry CD8-Positive T-Lymphocytes/immunology,virology Epitopes/chemistry Female Flow Cytometry HIV Infections/immunology,virology HIV-1/genetics Humans Male Peptides/chemistry Phenotype Sequence Analysis, DNA Viral Load Virus Replication
Chemicals
Anti-Retroviral Agents Antigens, Viral Epitopes Peptides
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Streeck Hendrik
Partners AIDS Research Center, Infectious Disease Unit, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, Massachusetts, United States of America.
Brumme Zabrina L
Anastario Michael
Cohen Kristin W
Jolin Jonathan S
Meier Angela
Brumme Chanson J
Rosenberg Eric S
Alter Galit
Allen Todd M
Walker Bruce D
Altfeld Marcus
References (44)
44 references, click to expand
  1. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
    J Virol. 2003 Feb;77(3):2081-92 PMID: 12525643
  2. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay.
    J Virol. 2000 Sep;74(18):8541-9 PMID: 10954555
  3. HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication.
    Lancet. 2004 Mar 13;363(9412):863-6 PMID: 15031033
  4. Viral immune evasion due to persistence of activated T cells without effector function.
    J Exp Med. 1998 Dec 21;188(12):2205-13 PMID: 9858507
  5. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation.
    Eur J Immunol. 2005 Mar;35(3):738-45 PMID: 15724249
  6. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells.
    J Exp Med. 2004 Sep 20;200(6):701-12 PMID: 15381726
  7. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
    Nat Med. 2002 May;8(5):493-9 PMID: 11984594
  8. Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression.
    J Virol. 1999 Nov;73(11):9153-60 PMID: 10516022
  9. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.
    Blood. 2000 Nov 1;96(9):3094-101 PMID: 11049989
  10. Restoring function in exhausted CD8 T cells during chronic viral infection.
    Nature. 2006 Feb 9;439(7077):682-7 PMID: 16382236
  11. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients.
    AIDS. 1999 Jun 18;13(9):1045-9 PMID: 10397534
  12. Methods for comparing a DNA sequence with a protein sequence.
    Comput Appl Biosci. 1996 Dec;12(6):497-506 PMID: 9021268
  13. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.
    J Virol. 2001 Jul;75(14):6508-16 PMID: 11413318
  14. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
    Nature. 2001 Mar 1;410(6824):106-11 PMID: 11242051
  15. Antigen-independent memory CD8 T cells do not develop during chronic viral infection.
    Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):16004-9 PMID: 15505208
  16. Memory CD8 T-cell differentiation during viral infection.
    J Virol. 2004 Jun;78(11):5535-45 PMID: 15140950
  17. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection.
    Immunity. 2007 Sep;27(3):393-405 PMID: 17892848
  18. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.
    Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1890-5 PMID: 9050875
  19. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.
    Nat Med. 2004 Aug;10(8):806-10 PMID: 15286782
  20. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy.
    J Virol. 1999 Aug;73(8):6721-8 PMID: 10400770
  21. Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression.
    Virology. 2002 Oct 25;302(2):393-404 PMID: 12441083
  22. Quality management of sequence-based methods for measuring HIV-1 drug resistance.
    Am Clin Lab. 2002 Jan-Feb;21(1):13-5 PMID: 11975443
  23. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.
    J Exp Med. 2006 Oct 2;203(10):2281-92 PMID: 16954372
  24. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
    Nature. 2006 Sep 21;443(7109):350-4 PMID: 16921384
  25. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic.
    Blood. 2003 Jan 1;101(1):226-35 PMID: 12393740
  26. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.
    Nat Immunol. 2003 Dec;4(12):1191-8 PMID: 14625547
  27. Molecular signature of CD8+ T cell exhaustion during chronic viral infection.
    Immunity. 2007 Oct;27(4):670-84 PMID: 17950003
  28. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
    Nat Med. 2006 Oct;12(10):1198-202 PMID: 16917489
  29. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection.
    J Exp Med. 2007 Apr 16;204(4):941-9 PMID: 17420267
  30. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.
    J Virol. 2003 Apr;77(8):4911-27 PMID: 12663797
  31. SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection.
    Blood. 2007 Aug 1;110(3):928-36 PMID: 17440051
  32. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
    Nat Immunol. 2002 Nov;3(11):1061-8 PMID: 12368910
  33. PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors.
    Blood. 2007 Jun 1;109(11):4671-8 PMID: 17272504
  34. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.
    J Exp Med. 1998 May 4;187(9):1383-93 PMID: 9565631
  35. HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha.
    Blood. 2004 Jul 15;104(2):487-94 PMID: 15059848
  36. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection.
    J Immunol. 2006 Nov 15;177(10):7406-15 PMID: 17082660
  37. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
    Nature. 2000 Sep 21;407(6802):386-90 PMID: 11014195
  38. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses.
    J Exp Med. 2007 Jun 11;204(6):1405-16 PMID: 17535971
  39. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.
    Blood. 2006 Jun 15;107(12):4781-9 PMID: 16467198
  40. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.
    J Exp Med. 2000 Jul 3;192(1):63-75 PMID: 10880527
  41. Limited durability of viral control following treated acute HIV infection.
    PLoS Med. 2004 Nov;1(2):e36 PMID: 15526059
  42. Immunology of hepatitis B virus and hepatitis C virus infection.
    Nat Rev Immunol. 2005 Mar;5(3):215-29 PMID: 15738952
  43. Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection.
    J Immunol. 2003 Oct 1;171(7):3837-46 PMID: 14500685
  44. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load.
    Eur J Immunol. 2004 Dec;34(12):3525-33 PMID: 15484193
Article Info
Journal
PLoS medicine
Abbr.
PLoS Med
ISSN
1549-1676
Published
2008-05-06
Pages
e100
Language
English
Region
United States
NLM ID
101231360
PMCID
PMC2365971
Subset
IM
Grants
NIAID NIH HHS · R01 AI050429 · United States
NIAID NIH HHS · U01 AI052403 · United States
NIAID NIH HHS · R01 AI50429 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com